Extremadura's biotech meeting aims to build a cohesive regional community to address global challenges through innovation. Focus areas include health, agriculture, and industry, showcasing local practices...
The biosimilars market is poised for growth driven by increased R&D investment, favorable regulations, and strategic industry partnerships. Key opportunities arise from the expiration of patents...
21 Invest has launched its first healthcare-focused fund, 21 Invest Healthcare, raising €70 million with a €150 million target. The Article 9 fund will invest €10–15...
ATB Therapeutics secured €54 million in Series A funding, one of Belgium's largest early-stage biotech raises. Backed by major global investors like EQT Life Sciences and...
Sanofi's €40M capital boost will scale Thymoglobulin production for kidney transplant rejection and internalize diabetes drug Tzield development, acquired via Provention Bio. The investment enhances reliability,...
Better Care and Oracle's partnership aims to revolutionize health data management, enhancing secure cloud storage and data flow efficiency. This collaboration supports faster diagnostics and treatments...
Brookfield agreed with Santander and Deutsche Bank to raise €11 billion for Grifols' debt refinancing, potentially Spain's largest syndicated loan. This funding is vital for Brookfield’s...
At an IDIS Foundation meeting, Abbott introduced two minimally invasive devices, MitraClip and TriClip, aimed at treating mitral and tricuspid regurgitation without open-heart surgery. Presented by...
Laminar Pharma raised €5.9 million, led by the Matutes family, for its growth and launch of anti-tumor drug LAM 561, aimed at glioblastoma treatment. Additional investors...
Bayer reported €4.18 billion in third-quarter losses, mainly due to agricultural division asset impairment. Revenues fell 3.6% to €9.97 billion, with agriculture down 8.7% and pharmaceuticals...